Streck Paul
CIK 0001708063
EVP, Head of R&D
Filings
9
Latest Mar 6, 2026
Issuers covered
2
Showing
9 of 9
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +40.7% | +73.1% | +73.1% | -24.0% |
| 90 days | 3 | 67% | +46.9% | +78.6% | +78.6% | -16.4% |
| 180 days | 1 | 100% | +317.1% | +317.1% | +317.1% | +317.1% |
| 365 days | 1 | 100% | +1.7% | +1.7% | +1.7% | +1.7% |
Issuers
Companies where Streck Paul has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PEPG | Pepgen Inc. | 6 | Mar 6, 2026 |
| ALBO | Albireo Pharma, Inc. | 3 | Mar 2, 2023 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|